Cargando…
2169. A 4-Year Analysis of Antimicrobial Susceptibility to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: How Drug Availability Affects Resistance Rate
BACKGROUND: Antibiotic resistance is associated with a fitness cost and reduced bacterial growth that allows susceptible bacteria to outcompete resistant bacteria, if selective pressure from antibiotics is reduced. Ceftolozane/tazobactam (C/T) approved in 2014, was temporarily withdrawn from Decembe...
Autores principales: | Imeneo, Alessandra, Campogiani, Laura, Di Lorenzo, Andrea, D’Agostini, Cartesio, Altieri, Anna, Malagnino, Vincenzo, Andreoni, Massimo, Iannetta, Marco, Sarmati, Loredana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677637/ http://dx.doi.org/10.1093/ofid/ofad500.1791 |
Ejemplares similares
-
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study
por: Campogiani, Laura, et al.
Publicado: (2023) -
Ceftolozane/Tazobactam for Treating Children With Exacerbations of Cystic Fibrosis Due to Pseudomonas aeruginosa: A Review of Available Data
por: Garazzino, Silvia, et al.
Publicado: (2020) -
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
por: Barnes, Melissa D., et al.
Publicado: (2018) -
Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia
por: Ruiz, Jesus, et al.
Publicado: (2020) -
Ceftolozane/Tazobactam Resistance and Mechanisms in Carbapenem-Nonsusceptible Pseudomonas aeruginosa
por: Teo, Jocelyn Qi-Min, et al.
Publicado: (2021)